Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight [Phase 2]

View source ↗

Summary

This clinical trial update announces a Phase 2 study evaluating the efficacy and safety of Maridebart Cafraglutide in adults with obesity or overweight and elev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Overweight or Obesity and Elevated Liver Fat | Phase 2 | Status: RECRUITING